Zinzino group revenue increased 18 % in Q3, compared with the previous year.
The revenue in September for Zinzino's sales markets increased by 15% and amounted to SEK 310.9 (270.8) million. Faun Pharma's external sales increased and amounted to SEK 6.4 (3.7) million. Overall, the Group increased revenues by 16% to SEK 317.3 (274.5) million compared with the previous year.
Revenue in Zinzino's sales markets increased by 18% in the third quarter of 2026 compared with the same period last year and amounted to SEK 917.3 (774.8) million. Total revenues in the Group increased by 18% in the third quarter and amounted to SEK 928.2 (784.1) million.
Accumulated revenue for January – September 2026 increased by 21% to SEK 2,787.1 (2,302.2) million.
Revenues were distributed as follows:
| Regions, mSEK | 26-Sep | 25-Sep | Change | Q3 2026 | Q3 2025 | Change | YTD 2026 | YTD 2025 | Change |
| The Nordics | 26.6 | 25.5 | 5% | 76.1 | 78.7 | -3% | 233.8 | 234.1 | 0% |
| Central Europe | 102.9 | 93.4 | 10% | 288.8 | 242.4 | 19% | 846.5 | 657.5 | 29% |
| East Europe | 25.5 | 29.3 | -13% | 76.7 | 89.6 | -14% | 243.0 | 276.0 | -12% |
| South & West Europe | 48.9 | 48.9 | 0% | 144.1 | 136.0 | 6% | 451.4 | 398.0 | 13% |
| The Baltics | 8.2 | 8.8 | -7% | 24.8 | 28.5 | -13% | 81.3 | 85.2 | -5% |
| North America | 62.2 | 39.8 | 56% | 195. | 126.1 | 55% | 596.4 | 373.7 | 60% |
| South America | 3.6 | 1.3 | 177% | 10.1 | 3.5 | 189% | 32.8 | 8.2 | 300% |
| Asia-Pacific | 30.9 | 22.0 | 40% | 95.1 | 64.2 | 48% | 237.2 | 213.2 | 11% |
| Africa | 2.1 | 1.9 | 11% | 6.5 | 5.8 | 12% | 18.8 | 16.0 | 18% |
| Zinzino | 310.9 | 270.8 | 15% | 917.3 | 774.8 | 18% | 2,741.2 | 2,261.9 | 21% |
| Faun Pharma | 6.4 | 3.7 | 73% | 10.9 | 9.3 | 17% | 45.9 | 40.3 | 14% |
| Zinzino Group | 317.3 | 274.5 | 16% | 928.2 | 784.1 | 18% | 2,787.1 | 2,302.2 | 21% |
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Portugal, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-South America: Peru, Colombia
-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea
-Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com
Fredrik Nielsen CFO Zinzino +46 707 900 174, fredrik.nielsen@zinzino.com
Pictures for publication free of charge: marketing@zinzino.com
Certified Adviser: Carnegie Investment Bank AB (publ)
Zinzino is a global health tech company from Scandinavia, pioneering a new standard in personal health through advanced home health tests and scientifically proven nutritional supplements. Listed on the Nasdaq First North Premier Growth Market, the company’s test-based, personalized nutrition strategy empowers individuals to take charge of their long-term health with science-based insights and targeted solutions. Its third-party validated products are available through direct sales distributors in more than 100 markets worldwide. Zinzino’s headquarters are located in Gothenburg, Sweden, with additional offices across Europe, Asia, and Australia.